An audit of pneumococcal and hepatitis vaccination in an outpatient HIV clinic

Sexual Health

Volumn 9, Issue 5, 2012, Pages 495-496

  Hunter, Michael G ^a,b   Post, Jeffrey J ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CD4 LYMPHOCYTE COUNT; HEPATITIS A; HEPATITIS B; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNIZATION; OUTCOME ASSESSMENT; OUTPATIENT; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMBULATORY CARE FACILITIES; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; NEW SOUTH WALES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; VACCINES, COMBINED; YOUNG ADULT;

EID: 84867639337     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH11192     Document Type: Article

References (11)

1. de Gaetano Donati K, Bertagnolio S, Tumbarello M, Tacconelli E, Cataldo M, Longo B, et al. Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. Int J Antimicrob Agents 2000; 16(3):3 57-60. doi:10.1016/S0924-8579(00)00265-X
2. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary complications of HIV Infection Study Group. N Engl J Med 1995; 333(13):8 45-51. doi:10.1056/NEJM199509283331305
3. Aspa J, Rajas O, Rodriguez de Castro F, Huertas MC, Borderias L, Cabello FJ, et al. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J 2006; 27(5):1 010-9. (Pubitemid 44911117)
4. Breiman RF, Keller DW, Phelan MA, Sniadack DH, Stephens DS, Rimland D, et al. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000; 160(17):2 633-8. doi:10.1001/archinte.160.17.2633
5. Rodriguez-Barradas MC, Goulet J, Brown S, Goetz MB, Rimland D, Simberkoff MS, et al. Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study. Clin Infect Dis 2008; 46(7):1 093-100. doi:10.1086/529201 (Pubitemid 351589878)
6. Hadler SC, Judson FN, O'Malley PM, Altman NL, Penley K, Buchbinder S, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991; 163(3):4 54-457. doi:10.1093/infdis/163.3.454
7. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 49: S138-45. doi:10.1002/hep.22883
8. Ferson MJ, Young LC, Stokes ML. Changing epidemiology of hepatitis A in the 1990s in Sydney, Australia. Epidemiol Infect 1998; 121(3):6 31-6. doi:10.1017/S0950268898001563 (Pubitemid 29023042)
9. National Health and Medical Research Council (NHMRC) The Australian immunisation handbook, 9th edition. Canberra: Department of Health and Aging; 2008.
10. Molton J, Smith C, Chaytor S, Maple P, Brown K, Johnson M, et al. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults. J Infect 2010; 61(1):7 3-80. doi:10.1016/j.jinf. 2010.04.004
11. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, et al. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136(9):6 41-51. (Pubitemid 34462676)